The global cell lysis & disruption market is projected to grow at a CAGR of 7%-9% during 2020-2025. The growth of cell lysis & disruption market is driven by increasing prevalence of diseases and disorders, increasing investment in research and development activities related to biotechnological process and academics, and growing focus on personalized medicines.
Some of the Key Questions answered in this exclusive report are:
Q.1 What are some of the
most promising, high-growth opportunities for the cell lysis & disruption market
by product (instruments (high-pressure homogenizers, sonicator, french press,
microfluidizer, bead mill, and other instruments) and reagents &
consumables (enzymes, detergent solutions (ionic detergent, nonionic detergent,
and zwitterionic detergent), and kits & reagents)), cell type (mammalian
cells, bacterial cells, yeast/algae/fungi, and plant cells), technique
(reagent-based (detergent and enzymatic) and physical disruption (mechanical
homogenization, ultrasonic homogenization, pressure homogenization, and
temperature treatments)), application (protein isolation, downstream
processing, cell organelle isolation, and nucleic acid isolation), end use
(academic & research institutes, hospitals & diagnostic labs, cell
banks, and pharmaceutical & biotechnology companies), and region (North
America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will
grow at a faster pace and why?
Q.3 What are the
business risks and threats to the cell lysis & disruption market?
Q.4 What are some
changing demands of customers in the cell lysis & disruption market?
Q.5 What are the new
developments in the cell lysis & disruption market? Which companies are
leading these developments?
Q.6 What strategic
initiatives are being implemented by key players for business growth?
Q.7 What are some of the
competitive products and processes in this cell lysis & disruption area and
how big of a threat do they pose for loss of market share via product substitution?
Q.8 What M&A
activity has occurred in the last 5 years in this cell lysis & disruption market?
Download Brochure of this report by clicking on https://www.lucintel.com/cell-lysis-aand-disruption-marke.aspx
Market Segmentation:
Based on product, the cell
lysis & disruption market is segmented into instruments (high-pressure
homogenizers, sonicator, french press, microfluidizer, bead mill, and other
instruments) and reagents and consumables (enzymes, detergent solutions (ionic
detergent, nonionic detergent, and zwitterionic detergent), and kits &
reagents). The reagents and consumables segment accounted for the largest share
of the market in 2020 due to rising prevalence of diseases and increasing
funding of cell-based research.
North America is
expected to be the largest region over the forecast period over the forecast
period due to increasing government initiatives related to research and development
and rising private and public investments for drug discovery and developing
treatment of complicated and rare diseases in the region.
Key Players in the cell lysis
& disruption market are Thermo Fisher Scientific, Merck, Roche, Qiagen,
B&D, Danaher, Bio-Rad Laboratories, Miltenyi Biotec, Claremont
BioSolutions, and Microfluidics International.
Request Sample Pages by clicking on https://www.lucintel.com/cell-lysis-aand-disruption-marke.aspx
The
report helps stakeholders understand the pulse of the market and provides them
with information on key drivers, restraints, challenges, and opportunities for
market growth. It would also help to understand the competitors better and gain
more insights to improve their position in the business.
To read more about this market please click on
https://www.lucintel.com/cell-lysis-aand-disruption-marke.aspx
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon
Fitzgerald
Lucintel
Dallas,
Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally
Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx
Endoscopy
Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx
Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx
Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor
Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx
Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx
Urology
Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx
Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx
No comments:
Post a Comment